Tri Locum Partners LP’s Xenon Pharmaceuticals Inc Position
Does Tri Locum Partners LP own Xenon Pharmaceuticals Inc (XENE)? Not currently — the last reported position was 366.1K shares worth $15M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$15M
Q3 2025
Shares
366.1K
% of Portfolio
+3.38%
Quarters Held
12
position exited
Position History XENE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 366.1K | $15M | +3.38% |
| Q2 2024 | 102.0K | $4M | +1.01% |
| Q1 2024 | 207.5K | $9M | +3.10% |
| Q4 2023 | 225.6K | $10M | +4.75% |
| Q3 2023 | 171.8K | $6M | +1.88% |
| Q2 2023 | 24.2K | $932,509 | +0.35% |
| Q1 2023 | 221.7K | $8M | +2.42% |
| Q4 2022 | 93.4K | $4M | +1.49% |
| Q3 2022 | 134.3K | $5M | +1.33% |
| Q2 2022 | 166.4K | $5M | +2.07% |
| Q4 2021 | 25.0K | $782,000 | +0.31% |
| Q3 2021 | 264.1K | $4M | +1.60% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tri Locum Partners LP’s full portfolio or all institutional holders of XENE.